Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 1.000 | 0.977 | 44 | 2007 | 2018 | |||||
Coronary heart disease
|
1178 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Fasting blood glucose measurement
|
212 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Fasting blood sugar result
|
113 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Gestational Diabetes
|
224 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.040 | 0.750 | 4 | 2009 | 2013 | |||||
Hypertensive disease
|
1085 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||
Impaired glucose tolerance
|
81 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||
Obesity
|
1111 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.020 | 1.000 | 2 | 2008 | 2015 | |||||
Breast Carcinoma
|
2793 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Cardiovascular Diseases
|
711 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Diabetes
|
710 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Diabetes Mellitus
|
824 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Diabetic Nephropathy
|
238 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Hyperglycemia
|
108 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Lymphatic Metastasis
|
10 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of breast
|
3417 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Metabolic Syndrome X
|
591 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Neoplasms
|
1644 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Prediabetes syndrome
|
16 | 0.724 | 0.400 | 3 | 185793899 | intron variant | G/T | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 |